graft-vs-host disease |
Disease ID | 834 |
---|---|
Disease | graft-vs-host disease |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:8) C0314719 | dry eye | 8 C0426768 | o sign | 5 C0023418 | leukemia | 4 C0026946 | fungal infections | 2 C0029166 | oral manifestations | 2 C0270922 | demyelinating polyneuropathy | 1 C0043541 | zygomycosis | 1 C0009450 | infection | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:3) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs1061622 | 14688526 | 7133 | TNFRSF1B | umls:C0018133 | BeFree | Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation. | 0.010639772 | 2003 | TNFRSF1B | 1 | 12192898 | T | G |
rs2275913 | 22028838 | 3605 | IL17A | umls:C0018133 | BeFree | When we examined the impact of rs2275913 in a cohort consisting of 438 pairs of patients and their unrelated donors transplanted through the Japan Marrow Donor Program, the donor IL-17 197A allele was found to be associated with a higher risk of acute graft-versus-host disease (GVHD; hazard ratio [HR], 1.46; 95% confidence interval [CI], 1.00 to 2.13; P = 0.05). | 0.120814326 | 2011 | IL17A | 6 | 52186235 | G | A |
rs4693608 | 24319286 | 10855 | HPSE | umls:C0018133 | BeFree | The study emphasizes the importance of rs4693608 SNP for HPSE gene expression in activated MNCs, indicating a role in allogeneic stem cell transplantation, including postconditioning, engraftment, and GVHD. | 0.003181358 | 2014 | HPSE | 4 | 83320204 | G | A |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:9) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0018133 | cyclophosphamide | D003520 | 50-18-0 | graft vs host disease | MESH:D006086 | therapeutic | 11014644 | ||
C0018133 | cyclosporine | D016572 | 59865-13-3 | graft vs host disease | MESH:D006086 | marker/mechanism | 21292993 | ||
C0018133 | cyclosporine | D016572 | 59865-13-3 | graft vs host disease | MESH:D006086 | therapeutic | 11100753 | ||
C0018133 | everolimus | D000068338 | - | graft vs host disease | MESH:D006086 | therapeutic | 19135948 | ||
C0018133 | methotrexate | D008727 | 1959/5/2 | graft vs host disease | MESH:D006086 | therapeutic | 14604289 | ||
C0018133 | sirolimus | D020123 | 53123-88-9 | graft vs host disease | MESH:D006086 | therapeutic | 15625544 | ||
C0018133 | tacrolimus | D016559 | 109581-93-3 | graft vs host disease | MESH:D006086 | therapeutic | 10918426 | ||
C0018133 | thalidomide | D013792 | 50-35-1 | graft vs host disease | MESH:D006086 | therapeutic | 12499476 | ||
C0018133 | vorinostat | C111237 | - | graft vs host disease | MESH:D006086 | therapeutic | 18347343 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |